GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Amedisys Inc (AMED) [hlAlert]

Rating:
Hold AMED

Amedisys Inc (AMED) rated Hold by BB&T Capital Mkts

Posted on: Thursday,  Jul 1, 2010  10:25 AM ET by BB&T Capital Mkts

Amedisys Inc (NASDAQ:
AMED) rated Hold by BB&T Capital Mkts.

Amedisys, Inc. (Amedisys) is a provider of home health services to the chronic, co-morbid, aging American population. The services that the Company provides include both home health and hospice services with approximately 87% of its revenue derived from Medicare. As of December 31, 2008, Amedisys owned and operated 480 Medicare-certified home health agencies, 48 Medicare-certified hospice agencies and managed the operations of four Medicare-certified home health and two Medicare-certified hospice agencies in 37 states within the United States, the District of Columbia and Puerto Rico. Its home health patient is Medicare eligible, approximately years old and takes approximately 12 different medications on a daily basis and has multiple co-morbidities. For the Company?s home health patients, it receives a 60-day, episodic-based payment from Medicare. On March 26, 2008, the Company completed the acquisition of TLC Health Care Services, Inc.

BB&T Capital Markets is dedicated to delivering world-class corporate banking, investment banking, and capital markets solutions to commercial clients, corporate clients, and government entities. Our customer focus and team approach, combined with the fast-growing strength and national recognition of BB&T, equip us to build lasting relationships and contribute significantly to the long-term success of each client.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/27/2011 10:25 AM Sell
None
13.59
as of 12/31/2010
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/1/2010 10:25 AM Hold
None
35.99
7/10/2007 9:25 AM Hold
None
36.35

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy